SLAYBACK PHARMA
Slayback is founded on the principle of โconnecting the dotsโ. This principle translates into their philosophy of connecting one idea with another. The idea is to conceptualize and develop complex generic and specialty drugs. They focus on products that are challenging and highly complex to develop and/or manufacture. It could be a complex oil-in-water emulsion or a sterile long acting injectable using nano-spheres or sterile suspensions with complex particle physics. They have also worked o... n complex hormonal products with challenging cross-contamination issues. They aim to optimize the use of technology and potential (generated from a strong experience in this field) to develop a value proposition for their customers. Through this process of drug development, they remotely aim at reducing the cost of therapy by bringing expensive branded drugs within the reach of patients.
SLAYBACK PHARMA
Social Links:
Industry:
Biopharma Manufacturing Pharmaceutical
Founded:
2011-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.slayback-pharma.com
Total Employee:
101+
Status:
Active
Contact:
609-945-3443
Email Addresses:
[email protected]
Total Funding:
110 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
BioQ Pharma
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EOC Pharma Group
EOC Pharma is an integrated biopharmaceutical company.
MAIA Pharmaceuticals
MAIA Pharmaceuticals identifies, develops, manufactures and markets innovative and niche generic products.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Reviva Pharmaceuticals
Reviva Pharmaceuticals is a clinical-stage pharmaceutical company developing innovative therapies.
Silk Therapeutics
Silk Therapeutics is a biotech company that offers skincare products for human health and wellness.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Everstone
Everstone investment in Series B - Slayback Pharma
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Private Equity Round - Slayback Pharma
Official Site Inspections
http://www.slayback-pharma.com Semrush global rank: 4.87 M Semrush visits lastest month: 1.81 K
- Host name: ip17.ip-192-95-16.net
- IP address: 192.95.16.17
- Location: Newark United States
- Latitude: 40.7265
- Longitude: -74.1782
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07102

More informations about "Slayback Pharma"
Slayback Pharma - LinkedIn
Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific โฆSee details»
Slayback Pharma - Crunchbase Company Profile & Funding
Slayback Pharma may be growing as indicated by the acquisition by Azurity Pharmaceuticals, which is a significant event that typically suggests confidence in the acquired company's value โฆSee details»
About Us โ Slayback-Pharma
About Us Slayback is a New Jersey -based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and โฆSee details»
Azurity Pharmaceuticals Acquires Slayback Pharma
Sep 27, 2023 Azurity Pharmaceuticals Acquires Slayback Pharma MEDIA ALERT: WOBURN, MA, September 27, 2023 โ Azurity Pharmaceuticals, Inc. (โAzurityโ) is pleased to announce โฆSee details»
Organization | Slayback Pharma Llc - Purdue University
Slayback Pharma Llc Report issue For profit Founded: Princeton NJ United States (2011) Status: Acquired by Azurity (2023)See details»
Slayback Pharma - Org Chart, Teams, Culture & Jobs | The Org
View Slayback Pharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Slayback Pharma Company Profile - Office Locations, Competitors โฆ
Slayback Pharma is a pharmaceutical company focused on developing, manufacturing, and sourcing of complex generic pharmaceuticals. It specializes in complex injectables and other โฆSee details»
Slayback Pharma Company Profile | Management and Employees โฆ
Slayback Pharma Profile and History Slayback is a New-Jersey based pharmaceutical company focused on the development of complex generic and specialty pharmaceutical products with a โฆSee details»
Slayback Pharma LLC - Company Profile and News
Company profile page for Slayback Pharma LLC including stock price, company news, executives, board members, and contact informationSee details»
Azurity Pharmaceuticals Acquires KKR-backed Slayback Pharma
WOBURN, MA โ Azurity Pharmaceuticals, Inc. (โAzurityโ) is pleased to announce the closing of its acquisition of Slayback Pharma LLC (โSlaybackโ) today from existing investors including KKR, โฆSee details»
Slayback Pharma - VentureRadar
"Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and โฆSee details»
Slayback-Pharma โ Connecting the Dots
Slayback is a New Jersey -based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and โฆSee details»
Slayback Pharma - Leadership Team | The Org
The Leadership Team at Slayback Pharma drives strategic direction and operational excellence, overseeing the development and commercialization of complex generic pharmaceuticals. โฆSee details»
Slayback Pharma LLC - Drug pipelines, Patents, Clinical trials
May 7, 2025 Explore Slayback Pharma LLC with its drug pipeline, therapeutic area, technology platform, 11 news, and 4 literature.See details»
Slayback Pharma - Funding, Financials, Valuation & Investors
Slayback Pharma believe every pharmaceutical product exhibits its own unique personality.See details»
Slayback Pharma - VentureRadar
Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and โฆSee details»
Slayback Pharma - Org chart | The Org
Explore Slayback Pharma's organizational chart. Discover current team members including executives, board members, and advisors.See details»
United States Court of Appeals for the Federal Circuit
Jun 30, 2025 SLAYBACK PHARMA LLC 9 the examiner of the novelty of the claims by underscoring absence of other active ingredients in the claimed meth-ods. The strongest โฆSee details»
Slayback Pharma 2025 Company Profile: Valuation, Investors
Information on acquisition, funding, investors, and executives for Slayback Pharma. Use the PitchBook Platform to explore the full profile.See details»
Slayback Pharma - Contacts, Employees, Board Members
Slayback Pharma has 3 current employee profiles, including Vice President of Operations Gyan Ranjan. Slayback Pharma has 3 board members and advisors, including Arjun Oberoi.See details»